INTRODUCTION: Although the spectrum of fungi causing bloodstream fungal infections continues to expand, Candida spp. remains responsible for the majority of these cases. OBJECTIVE: The purpose of this study was to characterize the candidemia epidemiology, species distribution and antifungal susceptibility patterns at a Brazilian tertiary teaching public hospital with 2,500 beds. METHODS: Records from the microbiology laboratory were used to identify patients with positive blood cultures during 2006. The in vitro activity of amphotericin B, caspofungin, itraconazole, fluconazole, voricanozole, and posaconazole were determined using the Etest method. RESULTS: One hundred and thirty-six cases of candidemia were identified and 100 strains were available for antifungal susceptibility testing. The overall incidence of candidemia was 1.87 cases/1.000 admissions and 0.27 cases/1.000 patient-days. Among the patients, 58.1% were male, and the median age was 40 years old. C. albicans was the most common species (52.2%), followed by C. parapsilosis (22.1%), C. tropicalis (14.8%), and C. glabrata (6.6%). All strains were susceptible to amphotericin B with a MIC90 of 0.5 µg/mL. Overall susceptibility for voriconozole, fluconazole, and caspofungin was > 97% with a MIC90 of 0.064, 4.0 and 1.0 µg/mL, respectively. For itraconazole the susceptibility rate was 81% with a MIC90 of 0.5 µg/mL. Posaconazole also demonstrated good in vitro activity with a MIC90 of 0.25 µg/mL. CONCLUSION: This is the first antifungal susceptibility report in our institution.
INTRODUCTION: Although the spectrum of fungi causing bloodstream fungal infections continues to expand, Candida spp. remains responsible for the majority of these cases. OBJECTIVE: The purpose of this study was to characterize the candidemia epidemiology, species distribution and antifungal susceptibility patterns at a Brazilian tertiary teaching public hospital with 2,500 beds. METHODS: Records from the microbiology laboratory were used to identify patients with positive blood cultures during 2006. The in vitro activity of amphotericin B, caspofungin, itraconazole, fluconazole, voricanozole, and posaconazole were determined using the Etest method. RESULTS: One hundred and thirty-six cases of candidemia were identified and 100 strains were available for antifungal susceptibility testing. The overall incidence of candidemia was 1.87 cases/1.000 admissions and 0.27 cases/1.000 patient-days. Among the patients, 58.1% were male, and the median age was 40 years old. C. albicans was the most common species (52.2%), followed by C. parapsilosis (22.1%), C. tropicalis (14.8%), and C. glabrata (6.6%). All strains were susceptible to amphotericin B with a MIC90 of 0.5 µg/mL. Overall susceptibility for voriconozole, fluconazole, and caspofungin was > 97% with a MIC90 of 0.064, 4.0 and 1.0 µg/mL, respectively. For itraconazole the susceptibility rate was 81% with a MIC90 of 0.5 µg/mL. Posaconazole also demonstrated good in vitro activity with a MIC90 of 0.25 µg/mL. CONCLUSION: This is the first antifungal susceptibility report in our institution.
Authors: M A De Francesco; G Piccinelli; M Gelmi; F Gargiulo; G Ravizzola; G Pinsi; L Peroni; C Bonfanti; A Caruso Journal: Mycopathologia Date: 2017-06-08 Impact factor: 2.574
Authors: Francesco Sbrana; Emanuela Sozio; Matteo Bassetti; Andrea Ripoli; Filippo Pieralli; Anna Maria Azzini; Alessandro Morettini; Carlo Nozzoli; Maria Merelli; Sebastiano Rizzardo; Giacomo Bertolino; Davide Carrara; Claudio Scarparo; Ercole Concia; Francesco Menichetti; Carlo Tascini Journal: Intern Emerg Med Date: 2018-01-10 Impact factor: 3.397
Authors: Ralciane de Paula Menezes; Joseane Cristina Ferreira; Walkiria Machado de Sá; Tomaz de Aquino Moreira; Lucivânia Duarte Silva Malvino; Lucio Borges de Araujo; Denise Von Dolinger de Brito Röder; Mario Paulo Amante Penatti; Regina Celia Candido; Reginaldo Dos Santos Pedroso Journal: Rev Inst Med Trop Sao Paulo Date: 2015 May-Jun Impact factor: 1.846
Authors: D K B Rodrigues; L X Bonfietti; R A Garcia; M R Araujo; J S Rodrigues; V M F Gimenes; M S C Melhem Journal: Braz J Med Biol Res Date: 2021-06-14 Impact factor: 2.590
Authors: Marcio Nucci; Flavio Queiroz-Telles; Tito Alvarado-Matute; Iris Nora Tiraboschi; Jorge Cortes; Jeannete Zurita; Manuel Guzman-Blanco; Maria Elena Santolaya; Luis Thompson; Jose Sifuentes-Osornio; Juan I Echevarria; Arnaldo L Colombo Journal: PLoS One Date: 2013-03-19 Impact factor: 3.240
Authors: João Nobrega de Almeida; Adriana Lopes Motta; Flávia Rossi; Edson Abdala; Ligia Camera Pierrotti; Adriana Satie Gonçalves Kono; Maria Del Pilar Estevez Diz; Gil Benard; Gilda Maria Barbaro Del Negro Journal: Clinics (Sao Paulo) Date: 2012-10 Impact factor: 2.365